Advanced Biomed (ADVB) Equity Ratio (2024 - 2026)

Advanced Biomed (ADVB) posted Equity Ratio of 0.87 for Q1 2026, down 1.0% sequentially from 0.87 in Q4 2025, and up 73.6% YoY from 0.5 in Q1 2025.

Advanced Biomed (ADVB) Equity Ratio (2024 - 2026) Analysis & Trends

Advanced Biomed (ADVB) has 3 years of Equity Ratio data on file, last reported at 0.87 in Q1 2026.

Quarterly Equity Ratio rose 73.6% year-over-year to 0.87 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.87 (up 73.6% YoY) and the FY2025 annual result came in at 0.25, down 32.02% from the prior year.
Equity Ratio retreated to 0.87 in Q1 2026 per ADVB's latest filing, from 0.87 in the prior quarter.
The five-year high for Equity Ratio was 0.87 in Q4 2025, with the low at 0.14 in Q4 2024.
Average Equity Ratio over 3 years is 0.5, with a median of 0.48 recorded in 2025.
The widest YoY moves for Equity Ratio: up 535.81% in 2025, down 32.02% in 2025.
Advanced Biomed's Equity Ratio stood at 0.14 in 2024, then surged by 535.81% to 0.87 in 2025, then decreased by 1.0% to 0.87 in 2026.
Business Quant data shows ADVB's Equity Ratio at 0.87 in Q1 2026, 0.87 in Q4 2025, and 0.48 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Ratio (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn	0.62
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn	0.46
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn	0.63
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn	0.46
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn	0.68
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn	-0.02
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn	0.21
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn	0.41
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn	-0.01
10	Advanced Biomed	6.22 Mn	6.22 Mn	-	0.87

Download Data